logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Mo Huang

merck & company usa

16H指数
69论文数
1.9K被引数
收录论文 23
发表时间
logo
Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose Optimization
errPharmaceutical Statistics
IF1.4
err2025-11-01
err0
errOAAI
errChen, Cong; Huang, Mo; Zhang, Xuekui
err分享
err收藏
A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors晚期实体瘤患者ERK抑制剂MK-8353联合pembrolizumab的1b期研究
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2024-09-14
err0
errOAAI
errLakhani, Nehal J.; Burris III, Howard; Miller Jr, Wilson H.; Huang, Mo; Chen, Lin-Chi; Siu, Lillian L.
err分享
err收藏
Results from KEYNOTE-B98: A phase 1b/2 study of pembrolizumab plus investigational agents in patients with anti-PD-(L)1-refractory extensive-stage small-cell lung cancer (ES-SCLC)
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errNavarro, Alejandro; Ahn, Myung-Ju; Stevenson, James; Peled, Nir; Kutiel, Talia Shentzer; Huemer, Florian; Kim, Dong-Wan; Casulleras, Maria Jove; Khattak, Adnan; Kowalski, Dariusz; Leighl, Natasha B.; de Marinis, Filippo; Lips, Carolin; Niu, Jiaxin; Huang, Mo; Zhao, Bin; El-Osta, Hazem; Owonikoko, Taofeek
err分享
err收藏
Statistical Interpretation and Comparison of Waterfall Plots
errJCO CLINICAL CANCER INFORMATICS
IF2.8
err2023-09-01
err0
PREAI
errHuang, Mo; Chen, Cong; Sun, Linda Z.
err分享
err收藏
Phase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN-mutated advanced solid tumors
errCANCER
IF5.1
err2023-03-27
err4
PREAI
errPant, Shubham; Hamilton, Erika; Ulahannan, Susanna V.; Strauss, James F.; Braiteh, Fadi S.; Huang, Mo; Liaw, Danny Chih Hsun
err分享
err收藏
Evaluation of event-free survival as a surrogate for overall survival in early-stage triple-negative breast cancer following neoadjuvant therapy
errANNALS OF ONCOLOGY
IF65.4
err2022-09-01
err2
PREAI
errFasching, P. A.; Huang, M.; Haiderali, A.; Xue, W.; Pan, W.; Karantza, V.; Yang, F.; Truscott, J.; Xin, Y.; O'Shaughnessy, J.
err分享
err收藏
Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic TNBC that expresses PD-L1
errANNALS OF ONCOLOGY
IF65.4
err2022-05-01
err0
errOAAI
errFasching, P. A.; Huang, M.; Haiderali, A.; Pan, W.; Hu, P.; Chaudhuri, M.; De Tilleghem, C. Le Bailly; Cappoen, N.; O'Shaughnessy, J.
err分享
err收藏
Cost effectiveness of pembrolizumab in combination with chemotherapy as neoadjuvant therapy and continued as a single agent as adjuvant therapy for high-risk early-stage TNBC in the United States
errANNALS OF ONCOLOGY
IF65.4
err2022-05-01
err3
errOAAI
errFasching, P. A.; Huang, M.; Haiderali, A.; Xue, W.; Pan, W.; Zhou, Z-Y.; Hu, P.; Chaudhuri, M.; De Tilleghem, C. Le Bailly; Cappoen, N.; O'Shaughnessy, J.
err分享
err收藏
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
errBLOOD ADVANCES
IF7.1
err2022-02-16
err18
errOAAI
errGregory, Gareth P.; Kumar, Shaji; Wang, Ding; Mahadevan, Daruka; Walker, Patricia; Wagner-Johnston, Nina; Escobar, Carolina; Bannerji, Rajat; Bhutani, Divaya; Chang, Julie; Hernandez-Ilizaliturri, Francisco J.; Klein, Andreas; Pagel, John M.; Rybka, Witold; Yee, Andrew J.; Mohrbacher, Anne; Huang, Mo; Farooqui, Mohammed; Marinello, Patricia; Quach, Hang
err分享
err收藏
Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab plus atezolizumab (TA) versus placebo plus atezolizumab (PA) as first-line treatment for PD-L1+NSCLC
errANNALS OF ONCOLOGY
IF65.4
err2021-12-01
err19
errOAAI
errCho, B. C.; Rodriguez-Abreu, D.; Hussein, M.; Cobo, M.; Patel, A.; Secen, N.; Gerstner, G.; Kim, D-W.; Lee, Y-G.; Su, W-C.; Huang, E.; Patil, N.; Huang, M.; Zhang, Z.; Wen, X.; Mendus, D.; Hoang, T.; Meng, R.; Johnson, M. L.
err分享
err收藏
KEYNOTE-B98: Phase Ib/II study of pembrolizumab plus investigational agents as second-line treatment for anti-PD-1/PD-L1-refractory extensive-stage small cell lung cancer (ES-SCLC)
errANNALS OF ONCOLOGY
IF65.4
err2021-12-01
err0
errOAAI
errLai, W. C. V.; Ahn, M-J.; Shentzer, T.; Kowalski, D.; Cho, B. C.; Schmid, S.; Jove, M.; Huang, M.; Zhao, B.; El-Osta, H.; Navarro, A.
err分享
err收藏
Data denoising with transfer learning in single-cell transcriptomics
errNATURE METHODS
IF32.1
err2019-08-30
err130
errOAAI
errWang, Jingshu; Agarwal, Divyansh; Huang, Mo; Hu, Gang; Zhou, Zilu; Ye, Chengzhong; Zhang, Nancy R.
err分享
err收藏
Gene expression distribution deconvolution in single-cell RNA sequencing单细胞RNA测序中的基因表达分布去卷积
errPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
err2018-06-26
err74
errOAAI
errWang, Jingshu; Huang, Mo; Torre, Eduardo; Dueck, Hannah; Shaffer, Sydney; Murray, John; Raj, Arjun; Li, Mingyao; Zhang, Nancy R.
err分享
err收藏
SAVER: gene expression recovery for single-cell RNA sequencing
errNATURE METHODS
IF32.1
err2018-06-25
err500
errOAAI
errHuang, Mo; Wang, Jingshu; Torre, Eduardo; Dueck, Hannah; Shaffer, Sydney; Bonasio, Roberto; Murray, John I.; Raj, Arjun; Li, Mingyao; Zhang, Nancy R.
err分享
err收藏
Design of an expression system to enhance MBP-mediated crystallization
errSCIENTIFIC REPORTS
IF3.9
err2017-01-23
err55
errOAAI
errJin, Tengchuan; Chuenchor, Watchalee; Jiang, Jiansheng; Cheng, Jinbo; Li, Yajuan; Fang, Kang; Huang, Mo; Smith, Patrick; Xiao, Tsan Sam
err分享
err收藏
COST-EFFECTIVENESS OF PEMBROLIZUMAB VS. DO CETAXEL FOR TREATMENT OF PREVIOUSLY TREATED PD-L1 POSITIVE ADVANCED NSCLC PATIENTS
errVALUE IN HEALTH
IF6
err2016-11-01
err1
PREAI
errHuang, M.; Lou, Y.; Pellissier, J.; Burke, T.; Liu, F. X.; Xu, R.; Velcheti, V.
err分享
err收藏
Initiator Integrated Poly(dimethysiloxane)-Based Microarray as a Tool for Revealing the Relationship between Nonspecific Interactions and Irreproducibility
errANALYTICAL CHEMISTRY
IF6.7
err2015-07-07
err12
PREAI
errHuang, Mo; Ma, Qing; Liu, Xing; Li, Boan; Ma, Hongwei
err分享
err收藏
CHARACTERIZATION OF HCV NS3 PROTEASE VARIANTS FROM PATIENTS ENROLLED IN A 28-DAY PHASE 2A TRIAL OF ACH-1625 DAILY DOSING PLUS PEGIFN-ALPHA 2A/RBV
errJOURNAL OF HEPATOLOGY
IF33
err2012-04-01
err3
PREAI
errFabrycki, J.; Patel, D.; Yang, G.; Zhao, Y.; Podos, S.; Robison, H.; Robarge, L.; Olek, E.; Deshpande, M.; Huang, M.
err分享
err收藏
A simple, high sensitivity mutation screening using Ampligase mediated T7 endonuclease I and Surveyor nuclease with microfluidic capillary electrophoresis
errELECTROPHORESIS
IF2.5
err2012-03-21
err54
PREAI
errHuang, Mo Chao; Cheong, Wai Chye; Lim, Li Shi; Li, Mo-Huang
err分享
err收藏
Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells
errLAB ON A CHIP
IF5.4
err2012-01-01
err183
PREAI
errLim, Li Shi; Hu, Min; Huang, Mo Chao; Cheong, Wai Chye; Gan, Alfred Tau Liang; Looi, Xing Lun; Leong, Sai Mun; Koay, Evelyn Siew-Chuan; Li, Mo-Huang
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Shaji Kumar
H 指数: 135 · 论文数: 2.2K
P
Peter A. Fasching
H 指数: 121 · 论文数: 2.1K
H
Howard A. Burris
H 指数: 117 · 论文数: 1.1K
M
Myung‐Ju Ahn
H 指数: 109 · 论文数: 1.3K
B
Byoung Chul Cho
H 指数: 106 · 论文数: 1.6K
查看更多